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Inoue Endovascular Graft (lEG) consisted of cylinder made from thin Dacron
sheet suspended by a framework of extra-flexible wire, We previously re-
ported that lEG was able to be successfUlly placed within the canine true
aneurysm. The purpose of this study is to examine whether lEG can be used
as a device for treatment of dissecting aneurysm. Aortic dissections (De-
Bakey type III) were created non-surgically in 10 dogs. The graft was de-
ployed through 15-F long sheath into the aneurysm to close the entry. The
graft size was chosen according to the diameter of the intact descending
aorta (distal to entry site) by aortography in the same way as true aneurysm
in 5 dogs (group I). In another 5 dogs (group II), the graft size was selected
according to the true lumen diameter by IVUS. The entry was completely
closed after immediate implantation in all dogs used in this study, All 5 dogs
in group I died as long as 11 days (mean, 7 days) after graft deployment. At
autopsy, 3 of 5 dogs showed ruptured aneurysmal wall caused byextravasa-
tion of graft. Remaining 2 dogs, in which entry was not completely covered
by graft, showed complete obstruction of aortic lumen induced by compres-
sion of false lumen, However, all grafts in group II were tolerated very well
and followed-up at 5 months after graft deployment. At that time, there was
6 hematoma, and 2 surgical repairs, one of which for AVfistula 22 days after
procedure. No bleeding requiring blood transfusion occurred.
Conclusion: This new PTRCA is a safe and effective way to perform coro-
nary revascularization with high initial success and low complication rate.
Achieving local hemostasis following coronary interventions especially in pa-
tients with massive anticoagulant therapy still remains a problem in clinical
cardiology. The objective of this study was to investigate the safety and effi-
cacyof a new biosealant (modified fibrin glue) and hemostatic device (Global
Therapeutics, Inc. I to reduce arterial compression time required to achieve
hemostasis at the arterial puncture site. 25 New Zealand rabbits (3-5 kg)
and 10 mongrel dogs (25-40 kg) were used in this study. 5F and 8F intro-
ducers were placed in the femoral arteries in rabbits and dogs respectively.
After complete heparinization the hemostatic device was introduced into
the puncture site through a guide wire and biosealant was applied to the
outside of the vessel. Immediately after removing hemostatic device a light
pressure was applied at the puncture site. Hemostasis was achieved in all
animals. Mean time for hemostasis was 1,2 ± 0.8 min and 5,6 ± 4.1 min
in rabbits and dogs respectively. Histopathology performed 1 month later of
the puncture site in dogs revealed complete reabsorbtion of biosealant with
re-endothelialization and no evidence of inflammation or hind limb thrombo-
sis. We conclude that the hemostatic device with biosealant is a safe and
effective method of hemostasis of arterial puncture sites,
Vascular access complication rate after PTCA is increased in elderly patients
(pts). The goal of this study is to determine whether the use of the new trans
radial approach (TRA) would decrease the rate of vascular complications.
Between February and August 1994, 135 consecutive pts ~70 years old un-
derwent a coronary angioplasty via TRA using a 6F guiding catheter. There
were 96 males, 39 females, with a mean age of 74.9 ± 3.8 years (70-87),
61 % had unstable angina, 17% had a recent myocardial infarction, 73% had
multivessel disease. Conventional balloon angioplasty was performed in 94
pts (70%), Palmaz-Schatz stent implantation in 29 pts (21 %) and rotational
ablation using the rotablator(l.25 or 1.5 mm burr diameter) in 12 pts (9%). In
hospital major cardiac events occurred in 3 pts (2%): one acute closure after
balloon angioplasty successfully recanalized, one non a-wave MI after rotab-
lator procedure and one death three days after coronary stent implantation,
Vascular access complications (2%) included 2 hematoma and one surgical
repair for A V fistula. No bleeding requiring blood transfusion occurred.
Conclusion: This new TRA for coronary revascularization in elderly can be
considered a safe and effective procedure, with a low rate of major cardiac
and arterial puncture site complications.
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1332 ± 342
51 ± 9
1548 ± 309
62 ± 8
Baseline-D-3
1247±218 NS
50 ± 8 NS
1522 ± 256 NS
60 ± 9 NS
1277 ± 281
54 ± 10
1350 ± 374
70 ± 12
Safety Evaluation of a New Infusion-Perfusion
Catheter: Vectocardiographic, Left Ventricular
and Coronary Hemodynamic During Local Drug
Delivery
Results: baseline occlusion hand pump APC
100 psi 200 psi 300 psi 400 psi
HR 116.8 1240 118.9 120.5 117.6 1192 129.2
Ibpmj ±11.4 ±14.7 ±163 ±163 ±31 ±157 ±16.9
AP 93.6 820 79.3 808 742 91.8 76.7
ImmHgl ±93 ±14.4 ±7.4 ±128 ±11.5 ±140 ±22.5
dp/dt 1662 1209 1544 1659 1715 1728 1416
[mmHg/s] ±356 ±435 ±316 ±369 ±567 ±409 ±400
EMF 48.9 0 30.7 456# 493# 64.1# 17.3
/ml/minJ ±28.1 ±378 ±436 ±460 ±541 ±9.1
WT 16.4 -2.7 3.2 57 102# 109# 2.4
I%J ±45 ±46 ±6.8 ±5.2 ±25 ±2.4 ±5.3
CPP 877 35.4 49.8 56.1 79.5# 101.7# 475
ImmHgJ ±14.1 ±33.6 ±31.8 ±261 ±445 ±61.3 ±480
# P < 0.05 vs. occlusion by ANOVA
Clo'se correlations were calculated between applied driVing pressures to
the hand pump and measured changes in dp/dt (r = 0.889). EMF (r = 0.948).
WT (r = 0.972) and CPP (r = 0.801).
Conclusion: The hand pump provides. depending on the applied driving
pressure. better distal coronary perfusion. hemodynamics and maintenance
of wall motion during PTCA compared to autoperfusion catheters.
+dP/dt (mmHg/sec) 1313 ± 195 NS
Vmax (sec1) 52 ± 8 NS
-dP/dt (mmHg/sec) 1634 ± 309
Tau1 (msee) 55 ± 10
Baseline-PTCA
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Percutaneous Trans Radial Coronary Angioplasty (PTRCA) was attempted in
515 consecutive patients (pts): 428 males, 87 females, mean age of 62.6 ±
10.7 years (31-87). 57% of pts had unstable angina, mean LVEF was 61.2
± 10.5% (25%-83%). 68% had multivessel disease. Failure to puncture the
radial artery occurred in 8 pts (1.5%) and to catheterize selectively the coro-
nary artery ostium in 7 pts (1.4%). These 15 pts underwent successful trans-
femoral PTCA and 500 pts effectively underwent PTRCA using a 6F catheter:
362 pts had conventional balloon angioplasty, 119 pts had coronary stenting
and 19 had rotational ablation, No acute major complications occurred during
the procedure. In hospital major cardiac events included one non a-wave MI
after rotablator procedure, one non a-wave MI (side branch occlusion) after
non elective stenting, and one death three days after non elective coronary
stenting, Bleeding orvascular access complications occurred in 8 pts(l ,6%):
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During intracoronary D-3 inflation basal and hyperaemic flow were 44 ±
31 ml/min and 78 ± 59 mllmin.
In conclusion this new infusion catheter allows a nearly normal basal coro-
nary flow with even preserved hyperaemic response during inflation and is
subjectively and hemodynamically well tolerated during prolonged inflation
permitting sustained local intracoronary drug delivery.
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Aim of the study was to assess adequacy of myocardial perfusion during
deployment of a new intracoronary drug delivery device (D-3. Dispatch '"
Scimed). In 22 patients (13 men, 57 ± 10 years) following conventional an-
gioplasty D-3 was inflated at the site of angioplasty. During inflation blood
velocity was measured distal to the device at baseline and after drug induced
hyperaemia. An angiography was performed to quantify the coronary cross-
sectional area at the site of Doppler sampling volume to calculate blood-flow.
Hemodynamic (high fidelity tip manometer-pigtail in the left ventriclel and
vectorcardiography was monitored continuously. During D-3 inflation (mean
inflation time 29 ± 8 min) 5 patients had mild chest pain. No significant vec-
torcardiographic changes were observed during prolonged inflation, Isovol-
umetric indices of contraction (+dP/dt, V max) and relaxation (-dP/dt, Tau1)
at baseline before PTCA and D-3, at the end of PTCA and D-3 inflation, re-
spectively, were as follows:
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